NED Biosystems Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NED Biosystems's estimated annual revenue is currently $1.6M per year.(i)
  • NED Biosystems's estimated revenue per employee is $155,000

Employee Data

  • NED Biosystems has 10 Employees.(i)
  • NED Biosystems grew their employee count by -9% last year.

NED Biosystems's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is NED Biosystems?

Pursuing No Evidence of Disease NED Biosystems™ is a clinical-stage biotech company developing innovative treatments unlike most available today. We begin with a focus on patients and their families. NED seeks to dramatically improve patients’ outcomes with therapies that lack the toxicity and side effects of today’s treatments, allowing patients a high quality of life. NED has initiated a multi-pronged approach to treating cancer through NED-170, the patented investigational cancer product that affects four key processes that advance all late-stage cancer with an anticipated well-tolerated safety profile. The same four processes that drive cancer are integral to COVID-19. NED has rapidly deployed its translational multi-pronged approach to the development of a prophylactic and treatment for COVID-19. NED-260, an investigational product, is designed to be the first orally administered combination for prophylaxis and treatment against COVID-19.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M10N/AN/A
#2
$0.9M10N/AN/A
#3
$0.9M10N/AN/A
#4
$0.9M10N/AN/A
#5
$0.8M10N/AN/A